Shanghai Pharmaceuticals (601607): Co-lead underwriter's report on the issuance process of Shanghai Pharmaceuticals Group Co., Ltd.'s non-public offering of A shares in 2021 and the compliance of subscribers CFi.CN Zhongcai.com

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000538 000540 002588 300713 China Securities China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Shanghai Pharmaceuticals Holding Shenzhenrease Technology Stanley Agriculture Group Xinjiang Sayram Modern Agriculture Yunnan Baiyao Group Zhongtian Financial Group Company Limited Crime, Law, Justice Design, Visual Arts Justice Law Regulations Shareholder Management Annual, Special Corporate Meeting Board Of Directors Pharmaceutical Design, Engineering Electricity Production, Distribution Financial, Business Service Market, Exchange Securities Stocks Diseases, Conditions Medicine People Club, Association Voting Party Transfer Pet Product, Service

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Shanghai Pharmaceuticals (601607): Co-lead underwriter's report on the issuance process of Shanghai Pharmaceuticals Group Co., Ltd.'s non-public offering of A shares in 2021 and the compliance of subscribers CFi.CN Zhongcai.com